Yuan-Hung Lo - Publications

Affiliations: 
Stanford University, Palo Alto, CA 

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Takashima S, Martin ML, Jansen SA, Fu Y, Bos J, Chandra D, O'Connor MH, Mertelsmann AM, Vinci P, Kuttiyara J, Devlin SM, Middendorp S, Calafiore M, Egorova A, Kleppe M, ... Lo Y, et al. T cell-derived interferon-γ programs stem cell death in immune-mediated intestinal damage. Science Immunology. 4. PMID 31811055 DOI: 10.1126/Sciimmunol.Aay8556  0.437
2018 Santos AJM, Lo YH, Mah AT, Kuo CJ. The Intestinal Stem Cell Niche: Homeostasis and Adaptations. Trends in Cell Biology. PMID 30195922 DOI: 10.1016/J.Tcb.2018.08.001  0.443
2018 Gracz AD, Samsa LA, Fordham MJ, Trotier DC, Zwarycz B, Lo YH, Bao K, Starmer J, Raab JR, Shroyer NF, Reinhardt RL, Magness ST. SOX4 Promotes ATOH1-independent Intestinal Secretory Differentiation Toward Tuft and Enteroendocrine Fates. Gastroenterology. PMID 30055169 DOI: 10.1053/J.Gastro.2018.07.023  0.337
2018 Zou WY, Blutt SE, Zeng XL, Chen MS, Lo YH, Castillo-Azofeifa D, Klein OD, Shroyer NF, Donowitz M, Estes MK. Epithelial WNT Ligands Are Essential Drivers of Intestinal Stem Cell Activation. Cell Reports. 22: 1003-1015. PMID 29386123 DOI: 10.1016/J.Celrep.2017.12.093  0.341
2018 Chen M, Lo Y, Shroyer NF. 593 - Limiting the Toxicity of Chemotherapy by Enhancing Regeneration of Intestinal Stem Cells Gastroenterology. 154: S-126. DOI: 10.1016/S0016-5085(18)30846-1  0.401
2018 Zou WY, Blutt SE, Zeng X, Chen M, Lo Y, Castillo-Azofeifa D, Kein OD, Shroyer NF, Donowitz M, Estes M. 430 - Epithelial-Secreted WNT Ligands are Essential Drivers of Intestinal Stem Cell Response to Virus-Induced Villus Damage Gastroenterology. 154: S-96. DOI: 10.1016/S0016-5085(18)30764-9  0.39
2018 Takashima S, Bos J, Chandra D, Jansen SA, O'Connor M, Mertelsmann AM, Calafiore M, Egorova A, Lo Y, Shroyer NF, Lindemans CA, Hanash AM. Interferon-γ Mediates Direct Intestinal Stem Cell Damage in Gastrointestinal Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.639  0.363
2017 Almohazey D, Lo YH, Vossler CV, Simmons AJ, Hsieh JJ, Bucar EB, Schumacher MA, Hamilton KE, Lau KS, Shroyer NF, Frey MR. The ErbB3 receptor tyrosine kinase negatively regulates Paneth cells by PI3K-dependent suppression of Atoh1. Cell Death and Differentiation. PMID 28304405 DOI: 10.1038/Cdd.2017.27  0.448
2017 Lo YH, Chung E, Li Z, Wan YW, Mahe MM, Chen MS, Noah TK, Bell KN, Yalamanchili HK, Klisch TJ, Liu Z, Park JS, Shroyer NF. Transcriptional Regulation by ATOH1 and its Target SPDEF in the Intestine. Cellular and Molecular Gastroenterology and Hepatology. 3: 51-71. PMID 28174757 DOI: 10.1016/J.Jcmgh.2016.10.001  0.413
2016 Lo Y, Noah TK, Chen M, Zou WY, Shroyer NF. 98 SPDEF Shifts the Transcriptional Targets of Activated β-Catenin in Quiescent Intestinal Tumor Cells Gastroenterology. 150: S25. DOI: 10.1016/S0016-5085(16)30209-8  0.377
2016 Parappilly M, Lo Y, Lantz T, Noah TK, Shroyer NF, Powell AE. 96 Insights into the Development of Gastrointestinal Brunner's Glands: Critical Stem Cells and Differentiation Factors Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)30207-4  0.378
2015 Gilbert S, Nivarthi H, Mayhew CN, Lo YH, Noah TK, Vallance J, Rülicke T, Müller M, Jegga AG, Tang W, Zhang D, Helmrath M, Shroyer N, Moriggl R, Han X. Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration. Stem Cell Reports. 4: 209-25. PMID 25579133 DOI: 10.1016/J.Stemcr.2014.12.004  0.444
2014 Zhao H, Chen MS, Lo YH, Waltz SE, Wang J, Ho PC, Vasiliauskas J, Plattner R, Wang YL, Wang SC. The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer. Oncogene. 33: 1429-37. PMID 23542172 DOI: 10.1038/Onc.2013.84  0.356
2014 Mahe MM, Lo Y, Watson CL, Sundaram N, Wang F, Karns R, Park J, Li L, Shroyer NF, Helmrath MA. 202 Intestinal Region-Specific Pattern Is Borne and Maintained Within the Intestinal Stem Cells Gastroenterology. 146: S-52-S-53. DOI: 10.1016/S0016-5085(14)60185-2  0.4
2014 Lo Y, Mahe MM, Chung E, Oh S, Park J, Shroyer NF. 139 ATOH1 Transcriptional Targets in the Adult Intestine Gastroenterology. 146: S-38-S-39. DOI: 10.1016/S0016-5085(14)60134-7  0.303
2013 Noah TK, Lo YH, Price A, Chen G, King E, Washington MK, Aronow BJ, Shroyer NF. SPDEF functions as a colorectal tumor suppressor by inhibiting β-catenin activity. Gastroenterology. 144: 1012-1023.e6. PMID 23376423 DOI: 10.1053/J.Gastro.2013.01.043  0.328
2013 Lo YH, Ho PC, Chen MS, Hugo E, Ben-Jonathan N, Wang SC. Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet. Biochemical and Biophysical Research Communications. 430: 43-8. PMID 23201573 DOI: 10.1016/J.Bbrc.2012.11.047  0.318
2013 Parang B, Reddy VK, Rosenblatt D, Williams A, Hunt A, Revetta F, Lo Y, Washington K, Engel M, Hiebert SW, Shroyer NF, Williams CS. 130 MTGR1 Is Required for Gsi-Induced Paneth Cell Differentiation Gastroenterology. 144: S-31. DOI: 10.1016/S0016-5085(13)60110-9  0.386
2012 Lo YH, Ho PC, Wang SC. Epidermal growth factor receptor protects proliferating cell nuclear antigen from cullin 4A protein-mediated proteolysis. The Journal of Biological Chemistry. 287: 27148-57. PMID 22692198 DOI: 10.1074/Jbc.M112.388843  0.348
2012 Zhao H, Ho PC, Lo YH, Espejo A, Bedford MT, Hung MC, Wang SC. Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer. Plos One. 7: e29416. PMID 22238610 DOI: 10.1371/Journal.Pone.0029416  0.322
2012 Zhao HJ, Ho P, Lo Y, Espejo A, Bedford MT, Hung M, Wang S. Abstract 3036: Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer Cancer Research. 72: 3036-3036. DOI: 10.1158/1538-7445.Am2012-3036  0.39
2011 Zhao H, Lo YH, Yu L, Wang SC. Overcoming resistance to fulvestrant (ICI182,780) by downregulating the c-ABL proto-oncogene in breast cancer. Molecular Carcinogenesis. 50: 383-9. PMID 21480391 DOI: 10.1002/Mc.20721  0.332
Show low-probability matches.